09:08 AM EDT, 07/28/2025 (MT Newswires) -- Cannabis producer Cannara Biotech ( LOVFF ) said Monday that its net income more than doubled in its fiscal third quarter ended May 31.

The company reported a net income of $4.1 million, or $0.04 per diluted share, rising from $2.0 million, or $0.02 per diluted share.

Total revenues jumped to $27.3 million from $19.5 million. Adjusted EBITDA climbed to $7.6 million from $2.8 million.

"Fiscal Q3 2025 represents another record-breaking quarter for Cannara, producing records for revenue, gross profit, gross margin, adjusted EBITDA, adjusted EBITDA margin, operating cash flow, and free cash flow, showcasing the successful execution of our long-term business strategy, as well as our industry leadership," said Zohar Krivorot, Cananra's president and CEO.